DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,755 filers reported holding DANAHER CORPORATION in Q1 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $722,865,797 | +1.8% | 2,913,606 | -1.5% | 0.52% | +7.0% |
| Q2 2023 | $709,880,810 | -7.0% | 2,957,836 | -2.3% | 0.48% | -11.2% |
| Q1 2023 | $763,081,541 | -1.6% | 3,027,620 | +3.6% | 0.55% | -6.5% |
| Q4 2022 | $775,409,954 | +5.0% | 2,921,445 | +2.2% | 0.58% | -0.5% |
| Q3 2022 | $738,348,000 | +2.3% | 2,858,596 | +0.4% | 0.59% | +9.9% |
| Q2 2022 | $721,919,000 | +2.0% | 2,847,584 | +18.0% | 0.53% | +19.7% |
| Q1 2022 | $707,743,000 | -8.9% | 2,412,789 | +1.9% | 0.45% | -3.9% |
| Q4 2021 | $777,064,000 | +11.9% | 2,367,925 | +3.8% | 0.46% | +2.4% |
| Q3 2021 | $694,286,000 | +13.5% | 2,280,536 | +0.0% | 0.45% | +14.7% |
| Q2 2021 | $611,951,000 | +30.9% | 2,280,334 | +9.8% | 0.40% | +20.1% |
| Q1 2021 | $467,496,000 | -1.5% | 2,077,021 | -2.8% | 0.33% | -6.5% |
| Q4 2020 | $474,853,000 | +8.9% | 2,137,630 | +5.5% | 0.35% | -4.1% |
| Q3 2020 | $436,180,000 | +22.0% | 2,025,635 | +0.2% | 0.37% | +16.5% |
| Q2 2020 | $357,411,000 | +30.4% | 2,021,215 | +2.1% | 0.32% | +4.0% |
| Q1 2020 | $274,001,000 | -11.1% | 1,979,644 | -1.4% | 0.30% | +17.9% |
| Q4 2019 | $308,235,000 | +2.0% | 2,008,312 | -4.0% | 0.26% | -3.7% |
| Q3 2019 | $302,248,000 | +4.9% | 2,092,691 | +3.8% | 0.27% | +3.1% |
| Q2 2019 | $288,131,000 | +13.6% | 2,016,033 | +4.9% | 0.26% | +9.7% |
| Q1 2019 | $253,608,000 | +29.1% | 1,920,984 | +0.8% | 0.24% | +12.9% |
| Q4 2018 | $196,468,000 | -21.4% | 1,905,237 | -17.2% | 0.21% | -5.0% |
| Q3 2018 | $250,080,000 | +12.4% | 2,301,490 | +2.0% | 0.22% | +7.3% |
| Q2 2018 | $222,562,000 | +18.7% | 2,255,393 | +17.8% | 0.20% | +14.5% |
| Q1 2018 | $187,519,000 | +7.8% | 1,915,209 | +2.2% | 0.18% | +11.9% |
| Q4 2017 | $174,027,000 | +9.5% | 1,874,889 | +1.2% | 0.16% | +3.9% |
| Q3 2017 | $158,909,000 | -6.5% | 1,852,509 | -8.0% | 0.15% | -9.4% |
| Q2 2017 | $169,915,000 | -9.8% | 2,013,446 | -8.5% | 0.17% | -25.1% |
| Q1 2017 | $188,289,000 | +52.1% | 2,201,448 | +38.4% | 0.23% | +44.6% |
| Q4 2016 | $123,818,000 | +28.6% | 1,590,674 | +29.5% | 0.16% | +23.6% |
| Q3 2016 | $96,255,000 | -14.8% | 1,227,902 | +9.7% | 0.13% | -19.6% |
| Q2 2016 | $113,014,000 | +9.1% | 1,118,946 | +2.5% | 0.16% | +5.3% |
| Q1 2016 | $103,556,000 | -1.4% | 1,091,665 | -3.5% | 0.15% | -3.8% |
| Q4 2015 | $105,050,000 | +3.1% | 1,131,027 | -5.4% | 0.16% | -2.5% |
| Q3 2015 | $101,864,000 | -32.3% | 1,195,448 | -32.0% | 0.16% | -28.6% |
| Q2 2015 | $150,430,000 | -5.7% | 1,757,572 | -6.5% | 0.22% | -5.9% |
| Q1 2015 | $159,555,000 | -9.8% | 1,879,343 | -8.9% | 0.24% | -13.5% |
| Q4 2014 | $176,812,000 | +9.7% | 2,062,905 | -2.8% | 0.28% | +0.7% |
| Q3 2014 | $161,197,000 | -5.4% | 2,121,573 | -2.0% | 0.27% | -4.9% |
| Q2 2014 | $170,466,000 | +108.3% | 2,165,190 | +98.4% | 0.29% | +96.6% |
| Q1 2014 | $81,831,000 | -5.8% | 1,091,079 | -3.0% | 0.15% | -9.9% |
| Q4 2013 | $86,826,000 | +12.0% | 1,124,681 | +0.6% | 0.16% | +1.2% |
| Q3 2013 | $77,494,000 | +8.4% | 1,117,921 | -1.0% | 0.16% | +1.3% |
| Q2 2013 | $71,463,000 | – | 1,128,953 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
| Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
| Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
| CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
| Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
| Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
| Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
| Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
| Third Point | 3,570,000 | $494,124,000 | 7.88% |